Sequoia Financial Advisors LLC bought a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 8,508 shares of the medical instruments supplier’s stock, valued at approximately $230,000.
Other hedge funds also recently bought and sold shares of the company. UMB Bank n.a. grew its stake in shares of DENTSPLY SIRONA by 430.3% in the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after buying an additional 753 shares in the last quarter. LRI Investments LLC increased its stake in shares of DENTSPLY SIRONA by 82.7% during the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock worth $31,000 after purchasing an additional 564 shares during the last quarter. Rothschild Investment LLC bought a new position in shares of DENTSPLY SIRONA during the 2nd quarter valued at $32,000. Central Pacific Bank Trust Division acquired a new stake in shares of DENTSPLY SIRONA in the 1st quarter valued at $64,000. Finally, GAMMA Investing LLC boosted its holdings in DENTSPLY SIRONA by 133.4% in the third quarter. GAMMA Investing LLC now owns 2,488 shares of the medical instruments supplier’s stock worth $67,000 after purchasing an additional 1,422 shares in the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of analysts have weighed in on the company. Stifel Nicolaus reduced their price target on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a research report on Thursday, July 18th. Barrington Research reaffirmed an “outperform” rating and set a $36.00 target price on shares of DENTSPLY SIRONA in a research report on Friday, September 20th. StockNews.com upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Monday. Evercore ISI reduced their price objective on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th. Finally, Needham & Company LLC lowered their target price on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research note on Friday, October 25th. Four investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat.com, DENTSPLY SIRONA has an average rating of “Moderate Buy” and a consensus price target of $32.67.
DENTSPLY SIRONA Price Performance
Shares of DENTSPLY SIRONA stock opened at $23.23 on Wednesday. The firm has a fifty day moving average price of $25.18 and a two-hundred day moving average price of $26.37. DENTSPLY SIRONA Inc. has a fifty-two week low of $22.85 and a fifty-two week high of $37.60. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.33 and a quick ratio of 0.87. The company has a market cap of $4.71 billion, a PE ratio of -27.34, a price-to-earnings-growth ratio of 1.12 and a beta of 1.00.
DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last released its earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The firm had revenue of $984.00 million for the quarter, compared to analyst estimates of $993.61 million. During the same period last year, the business earned $0.51 earnings per share. The firm’s quarterly revenue was down 4.3% compared to the same quarter last year. Analysts expect that DENTSPLY SIRONA Inc. will post 1.98 EPS for the current year.
DENTSPLY SIRONA Profile
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Featured Articles
- Five stocks we like better than DENTSPLY SIRONA
- What Are Dividend Contenders? Investing in Dividend Contenders
- Is McDonald’s Stock a Smart Buy After Sell-Off and Earnings?
- What Are the FAANG Stocks and Are They Good Investments?
- QuantumScape: Solid State EV Batteries Nearing Commercialization
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- MicroStrategy: Is This Bitcoin-Powered Stock a Buy or a Gamble?
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.